Screener
Charles River Laboratories CRL Restructuring Charges
Restructuring Charges at other companies
Segments
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| RMS | $7,748 | $7,419 | $25,380 | $8,843 |
| DSA | 7,007 | 16,076 | 13,887 | 33,618 |
| Manufacturing | 717 | 7,444 | 1,179 | 11,155 |
| Unallocated corporate | 7,585 | 1,261 | 14,191 | 2,429 |
| Total | $23,057 | $32,200 | $54,637 | $56,045 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's restructuring charges?
- Charles River Laboratories (CRL) reported restructuring charges of $23.06M in Q2 2026.
- How has Charles River Laboratories's restructuring charges changed year-over-year?
- Charles River Laboratories's restructuring charges decreased by 28.4% year-over-year, from $32.2M to $23.06M.
- What is the long-term trend for Charles River Laboratories's restructuring charges?
- Over 2 years (2023 to 2025), Charles River Laboratories's restructuring charges has grown at a 83.4% compound annual growth rate (CAGR), from $29.68M to $99.81M.
- What does restructuring charges mean?
- One-time costs from reorganizing operations, including employee severance, facility closure costs, contract termination fees, and asset relocation expenses.
Ask your AI about Charles River Laboratories's restructuring charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude